Ezetimibe and Statin Comparison

All of the patients were randomly assigned to receive ezetimibe 10 mg and statin N mg (E/S) or statin 2 N mg (D/S). The efficacy of reducing LDL-C, TC and HDL-C concentrations in the two groups was recorded. All patients were assessed for LDL-C, TC and HDL-C level at end point time between the E/S and D/S treatment groups from baseline.

Free full text: Click here

Yu M., Liang C., Kong Q., Wang Y, & Li M. (2020). Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature. Lipids in Health and Disease, 19, 1.

Publication 2020

Ezetimibe Patients Statin

Corresponding Organization :

Other organizations : First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Xinqiao Hospital, Army Medical University

Top 5 similar protocols

Protocol cited in 7 other protocols

Variable analysis

independent variables

Ezetimibe 10 mg and statin N mg (E/S)
Statin 2 N mg (D/S)

dependent variables

LDL-C concentration
TC concentration
HDL-C concentration

control variables

Patients were randomly assigned to the treatment groups

controls

The two treatment groups (E/S and D/S) serve as the positive and negative controls for each other.

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!